BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 23999134)

  • 1. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
    Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
    Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
    Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.
    Meyer S; Schaefer S; Stolk L; Arp P; Uitterlinden AG; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Weise A; Pfützner A; Kann PH
    Pharmacogenomics; 2009 Oct; 10(10):1599-608. PubMed ID: 19842933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The exon 3 deleted growth hormone receptor gene is associated with small birth size and early pubertal onset in healthy boys.
    Sørensen K; Aksglaede L; Petersen JH; Leffers H; Juul A
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2819-26. PubMed ID: 20382688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.
    Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K
    Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
    Tauber M; Ester W; Auriol F; Molinas C; Fauvel J; Caliebe J; Nugent T; Fryklund L; Ranke MB; Savage MO; Clark AJ; Johnston LB; Hokken-Koelega AC;
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
    Mericq V; Román R; Iñiguez G; Angel B; Salazar T; Avila A; Perez-Bravo F; Cassorla F
    Horm Res; 2007; 68(3):132-8. PubMed ID: 17347571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between GH receptor polymorphism (exon 3 deletion), serum IGF1, semen quality, and reproductive hormone levels in 838 healthy young men.
    Andreassen M; Jensen RB; Jørgensen N; Juul A
    Eur J Endocrinol; 2014 Apr; 170(4):555-63. PubMed ID: 24412931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between exon 3 polymorphism of growth hormone receptor gene and the responses to rhGH therapy.
    Wei Y; Zheng R; Zhou Y; Wang J; Bao P
    Int J Clin Exp Pathol; 2015; 8(6):7371-7. PubMed ID: 26261638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults.
    Hartleb S; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Pfützner A; Kann PH; ;
    Pharmacogenomics; 2011 Dec; 12(12):1653-61. PubMed ID: 22026923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.
    Pantel J; Grulich-Henn J; Bettendorf M; Strasburger CJ; Heinrich U; Amselem S
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1705-10. PubMed ID: 12679461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
    Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone receptor (GHR) exon 3 polymorphism status detection by dual-enzyme-linked immunosorbent assay (ELISA).
    Wan J; Atzmon G; Hwang D; Barzlai N; Kratzsch J; Cohen P
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E77-81. PubMed ID: 23162096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common exon 3 polymorphism of the GH receptor (GHR) gene and effect of GH therapy on growth in Korean children with idiopathic short stature (ISS).
    Ko JM; Park JY; Yoo HW
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):82-7. PubMed ID: 18793346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
    Hujeirat Y; Hess O; Shalev S; Tenenbaum-Rakover Y
    Horm Res; 2006; 65(4):210-6. PubMed ID: 16582564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
    Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA; Arnhold IJ
    Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.
    Kucukhuseyin O; Toptas B; Timirci-Kahraman O; Isbir S; Karsidag K; Isbir T
    In Vivo; 2015; 29(3):371-8. PubMed ID: 25977383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor.
    Blum WF; Machinis K; Shavrikova EP; Keller A; Stobbe H; Pfaeffle RW; Amselem S
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4171-4. PubMed ID: 16868057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.